Increased α-Defensins 1-3 Production by Dendritic Cells in HIV-Infected Individuals Is Associated with Slower Disease Progression

• Marta Rodríguez-García,

  Current address: The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Boston, Massachusetts, United States of America

  Affiliations Services of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)-AIDS Research Group, and Catalonian Center for HIV Vaccines (HIVACAT), Barcelona, Spain

  ⨯
• Núria Climent ,

  Contributed equally to this work with: Núria Climent, Harold Oliva

  Affiliations Services of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)-AIDS Research Group, and Catalonian Center for HIV Vaccines (HIVACAT), Barcelona, Spain

  ⨯
• Harold Oliva ,

  Contributed equally to this work with: Núria Climent, Harold Oliva

  Affiliations Services of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)-AIDS Research Group, and Catalonian Center for HIV Vaccines (HIVACAT), Barcelona, Spain

  ⨯
• Víctor Casanova,

  Affiliations Hospital Clínic de Barcelona, University of Barcelona School of Medicine, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), and Department of Biochemistry and Molecular Biology, Barcelona, Spain

  ⨯
• Rafael Franco,

  Affiliations Hospital Clínic de Barcelona, University of Barcelona School of Medicine, Barcelona, Spain, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), and Department of Biochemistry and Molecular Biology, Barcelona, Spain, Faculty of Biology, University of Barcelona, Barcelona, Spain, Centro de Investigación Médica Aplicada, University of Navarra, Pamplona, Spain

  ⨯
• Agathe Leon,

  Affiliations Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)-AIDS Research Group, and Catalonian Center for HIV Vaccines (HIVACAT), Barcelona, Spain, Infectious Diseases and AIDS Unit, Hospital Clínic de Barcelona, Barcelona, Spain

  ⨯
• José M. Gatell,

  Affiliations Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)-AIDS Research Group, and Catalonian Center for HIV Vaccines (HIVACAT), Barcelona, Spain, Infectious Diseases and AIDS Unit, Hospital Clínic de Barcelona, Barcelona, Spain

  ⨯
• Felipe García,

  Affiliations Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)-AIDS Research Group, and Catalonian Center for HIV Vaccines (HIVACAT), Barcelona, Spain, Infectious Diseases and AIDS Unit, Hospital Clínic de Barcelona, Barcelona, Spain

  ⨯
• Teresa Gallart

  * E-mail: TGALLART@clinic.ub.es

  Affiliations Services of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS)-AIDS Research Group, and Catalonian Center for HIV Vaccines (HIVACAT), Barcelona, Spain

  ⨯